Medline, Inc. Laboratory and Diagnostics — Net Sales increased by 0.7% to $293.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $291.00M to $293.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing demand for diagnostic testing supplies and successful expansion of the laboratory product portfolio, while a decrease may signal market saturation, increased competition, or reduced clinical testing volumes.
This metric represents the total revenue generated from the sale of laboratory equipment, diagnostic testing supplies, a...
Comparable to diagnostic product revenue segments at diversified medical device and life sciences companies, often benchmarked against broader clinical laboratory supply market growth rates.
mdln_segment_laboratory_and_diagnostics_net_sales| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $209.25M | $209.25M | $209.25M | $209.25M | $239.00M | $239.00M | $239.00M | $239.00M | $291.00M | $293.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.2% | +0.0% | +0.0% | +0.0% | +21.8% | +0.7% |
| YoY Change | — | — | — | — | +14.2% | +14.2% | +14.2% | +14.2% | +21.8% | +0.7% |